scholarly article | Q13442814 |
P8978 | DBLP publication ID | journals/ploscb/CarboHKVPLPHMEBWJMB13 |
P356 | DOI | 10.1371/JOURNAL.PCBI.1003027 |
P932 | PMC publication ID | 3617204 |
P698 | PubMed publication ID | 23592971 |
P5875 | ResearchGate publication ID | 236207342 |
P50 | author | Barbara Kronsteiner | Q41047888 |
Stephen Eubank | Q41047902 | ||
Abdul Jarrah | Q57193520 | ||
Pinyi Lu | Q59677379 | ||
Josep Bassaganya-Riera | Q62066149 | ||
Madhav Marathe | Q63015429 | ||
Katherine Wendelsdorf | Q66305652 | ||
Keith Bisset | Q66305655 | ||
Raquel Hontecillas | Q66305659 | ||
Monica Viladomiu | Q66305665 | ||
Adria Carbo | Q66305670 | ||
Casandra W. Philipson | Q67103830 | ||
Mireia Pedragosa | Q67123597 | ||
Stefan Hoops | Q30303478 | ||
P2093 | author name string | Yongguo Mei | |
P2860 | cites work | Single-cell quantification of IL-2 response by effector and regulatory T cells reveals critical plasticity in immune response | Q41472662 |
IL-22-producing CD4+ T cells: middle-men between the immune system and its environment | Q42920577 | ||
Peroxisome proliferator-activated receptor gamma is required for regulatory CD4+ T cell-mediated protection against colitis | Q44927266 | ||
IFN-gamma suppresses STAT6 phosphorylation by inhibiting its recruitment to the IL-4 receptor | Q45231996 | ||
T-regulatory 1 cells: a novel subset of CD4 T cells with immunoregulatory properties. | Q45869113 | ||
Human CD25highFoxp3pos regulatory T cells differentiate into IL-17-producing cells | Q46490320 | ||
IL-17+ regulatory T cells in the microenvironments of chronic inflammation and cancer. | Q46885750 | ||
Sequential polarization and imprinting of type 1 T helper lymphocytes by interferon-gamma and interleukin-12. | Q47898451 | ||
Interferons direct Th2 cell reprogramming to generate a stable GATA-3(+)T-bet(+) cell subset with combined Th2 and Th1 cell functions. | Q50711339 | ||
Human T helper (Th) cell lineage commitment is not directly linked to the secretion of IFN-gamma or IL-4: characterization of Th cells isolated by FACS based on IFN-gamma and IL-4 secretion. | Q50959583 | ||
Human tumor-infiltrating Th17 cells have the capacity to differentiate into IFN-γ+ and FOXP3+ T cells with potent suppressive function. | Q51887184 | ||
The nuclear receptor PPAR gamma and immunoregulation: PPAR gamma mediates inhibition of helper T cell responses | Q73368153 | ||
Peroxisome proliferator-activated receptor gamma (PPARgamma) and immunoregulation: enhancement of regulatory T cells through PPARgamma-dependent and -independent mechanisms | Q79984782 | ||
A network model for the control of the differentiation process in Th cells | Q82137174 | ||
Inhibition of interleukin-17 promotes differentiation of CD25⁻ cells into stable T regulatory cells in patients with autoimmune hepatitis | Q83566115 | ||
CD28 co-stimulation down regulates Th17 development | Q21143804 | ||
TGF-beta-induced Foxp3 inhibits T(H)17 cell differentiation by antagonizing RORgammat function | Q24314628 | ||
Characterization of interleukin-17-producing regulatory T cells in inflamed intestinal mucosa from patients with inflammatory bowel diseases | Q24607561 | ||
A whole-cell computational model predicts phenotype from genotype | Q24622101 | ||
The differentiation of human T(H)-17 cells requires transforming growth factor-beta and induction of the nuclear receptor RORgammat | Q24648890 | ||
Reciprocal developmental pathways for the generation of pathogenic effector TH17 and regulatory T cells | Q27860460 | ||
The orphan nuclear receptor RORgammat directs the differentiation program of proinflammatory IL-17+ T helper cells | Q27860620 | ||
The control of flux | Q28237216 | ||
A Linear Steady-State Treatment of Enzymatic Chains. General Properties, Control and Effector Strength | Q28246120 | ||
COPASI--a COmplex PAthway SImulator | Q29617467 | ||
Molecular antagonism and plasticity of regulatory and inflammatory T cell programs | Q29619478 | ||
The role of peroxisome proliferator-activated receptor γ in immune responses to enteroaggregative Escherichia coli infection | Q30422017 | ||
Modeling the role of peroxisome proliferator-activated receptor γ and microRNA-146 in mucosal immune responses to Clostridium difficile | Q30424551 | ||
Peroxisome proliferator-activated receptor α and γ agonists together with TGF-β convert human CD4+CD25- T cells into functional Foxp3+ regulatory T cells | Q33740542 | ||
Plasticity of human Th17 cells and iTregs is orchestrated by different subsets of myeloid cells | Q33873201 | ||
A mathematical model for the reciprocal differentiation of T helper 17 cells and induced regulatory T cells | Q33987374 | ||
All-trans retinoic acid promotes TGF-β-induced Tregs via histone modification but not DNA demethylation on Foxp3 gene locus | Q34023732 | ||
Immune response to Bifidobacterium bifidum strains support Treg/Th17 plasticity | Q34037796 | ||
Cutting edge: CTLA-4--B7 interaction suppresses Th17 cell differentiation | Q34041965 | ||
Th17 plasticity in human autoimmune arthritis is driven by the inflammatory environment | Q34093086 | ||
TGF-beta and IL-6 drive the production of IL-17 and IL-10 by T cells and restrain T(H)-17 cell-mediated pathology | Q34712326 | ||
Plasticity of CD4+ T cell lineage differentiation. | Q34982725 | ||
Suppression of TH17 differentiation and autoimmunity by a synthetic ROR ligand | Q35143424 | ||
Digoxin and its derivatives suppress TH17 cell differentiation by antagonizing RORγt activity | Q35210669 | ||
Quantifying crosstalk among interferon-γ, interleukin-12, and tumor necrosis factor signaling pathways within a TH1 cell model | Q36027002 | ||
Dynamics of CD4(+) T cell responses against Listeria monocytogenes | Q36417402 | ||
The Hill equation: a review of its capabilities in pharmacological modelling | Q37339368 | ||
The nuclear receptor PPAR gamma selectively inhibits Th17 differentiation in a T cell-intrinsic fashion and suppresses CNS autoimmunity | Q37377446 | ||
IL-9: basic biology, signaling pathways in CD4+ T cells and implications for autoimmunity | Q37658504 | ||
Interleukin-23 and T helper 17-type responses in intestinal inflammation: from cytokines to T-cell plasticity | Q37883457 | ||
Late developmental plasticity in the T helper 17 lineage | Q39265291 | ||
FoxP3+RORgammat+ T helper intermediates display suppressive function against autoimmune diabetes | Q39752246 | ||
P275 | copyright license | Creative Commons Attribution 4.0 International | Q20007257 |
P6216 | copyright status | copyrighted | Q50423863 |
P433 | issue | 4 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | phenotype | Q104053 |
phenotypic plasticity | Q295130 | ||
cell differentiation | Q210861 | ||
P304 | page(s) | e1003027 | |
P577 | publication date | 2013-04-04 | |
P1433 | published in | PLOS Computational Biology | Q2635829 |
P1476 | title | Systems modeling of molecular mechanisms controlling cytokine-driven CD4+ T cell differentiation and phenotype plasticity | |
P478 | volume | 9 |
Q38564348 | (Compl)Ex-Th17-Treg cell inter-relationship |
Q58803375 | A Mechanistic Computational Model Reveals That Plasticity of CD4 T Cell Differentiation Is a Function of Cytokine Composition and Dosage |
Q35668576 | A Minimal Regulatory Network of Extrinsic and Intrinsic Factors Recovers Observed Patterns of CD4+ T Cell Differentiation and Plasticity. |
Q90342327 | A case for the reuse and adaptation of mechanistic computational models to study transplant immunology |
Q52364429 | A systems pharmacology model for inflammatory bowel disease. |
Q59138191 | Analysis of selected T cell subsets in peripheral blood after exhaustive effort among elite soccer players |
Q31025232 | Analyzing Th17 cell differentiation dynamics using a novel integrative modeling framework for time-course RNA sequencing data |
Q37097646 | Animal models of enteroaggregative Escherichia coli infection |
Q35360459 | Cellular Plasticity of CD4+ T Cells in the Intestine |
Q37098405 | Cellular and population plasticity of helper CD4(+) T cell responses |
Q34391413 | Computational modeling of heterogeneity and function of CD4+ T cells |
Q91057942 | Dynamic balance of pro- and anti-inflammatory signals controls disease and limits pathology |
Q37490734 | Elevated peripheral frequencies of Th22 cells: a novel potent participant in obesity and type 2 diabetes |
Q35414220 | Emerging significance of NLRs in inflammatory bowel disease |
Q46341919 | Empirical modeling of T cell activation predicts interplay of host cytokines and bacterial indole. |
Q93088297 | From Discrete to Continuous Modeling of Lymphocyte Development and Plasticity in Chronic Diseases |
Q28607856 | Goals in Nutrition Science 2015-2020 |
Q64936477 | High-resolution computational modeling of immune responses in the gut. |
Q47668620 | Informatics for Nutritional Genetics and Genomics |
Q92430825 | Interleukin-21 (IL-21) Downregulates Dendritic Cell Cytokine Responses to Helicobacter pylori and Modulates T Lymphocyte IL-17A Expression in Peyer's Patches during Infection |
Q36098058 | Mathematical Modeling of Early Cellular Innate and Adaptive Immune Responses to Ischemia/Reperfusion Injury and Solid Organ Allotransplantation |
Q36242558 | Modeling the Mechanisms by Which HIV-Associated Immunosuppression Influences HPV Persistence at the Oral Mucosa |
Q34494038 | Modeling the Regulatory Mechanisms by Which NLRX1 Modulates Innate Immune Responses to Helicobacter pylori Infection |
Q36217991 | Modeling the Role of Lanthionine Synthetase C-Like 2 (LANCL2) in the Modulation of Immune Responses to Helicobacter pylori Infection |
Q26766623 | Modeling-Enabled Systems Nutritional Immunology |
Q46246507 | Modulation of Immune Signaling and Metabolism Highlights Host and Fungal Transcriptional Responses in Mouse Models of Invasive Pulmonary Aspergillosis |
Q26741117 | Mucosal Interactions between Genetics, Diet, and Microbiome in Inflammatory Bowel Disease |
Q35761666 | Multiscale modeling of mucosal immune responses |
Q40346038 | NLRX1 Regulates Effector and Metabolic Functions of CD4+ T Cells. |
Q92744216 | O-GlcNAcylation in immunity and inflammation: An intricate system (Review) |
Q34988965 | Predictive computational modeling of the mucosal immune responses during Helicobacter pylori infection |
Q58803267 | Role of Cytokine Combinations on CD4+ T Cell Differentiation, Partial Polarization, and Plasticity: Continuous Network Modeling Approach |
Q35761127 | Sensitivity Analysis of an ENteric Immunity SImulator (ENISI)-Based Model of Immune Responses to Helicobacter pylori Infection |
Q58803374 | Simulation of Stimulation: Cytokine Dosage and Cell Cycle Crosstalk Driving Timing-Dependent T Cell Differentiation |
Q40574683 | Supervised learning methods in modeling of CD4+ T cell heterogeneity |
Q35729663 | Systems Modeling of Interactions between Mucosal Immunity and the Gut Microbiome during Clostridium difficile Infection |
Q33995331 | Systems modeling of the role of interleukin-21 in the maintenance of effector CD4+ T cell responses during chronic Helicobacter pylori infection |
Q35945226 | Systems-wide analyses of mucosal immune responses to Helicobacter pylori at the interface between pathogenicity and symbiosis |
Q64890547 | T Cell Subsets' Distribution in Elite Karate Athletes as a Response to Physical Effort. |
Q92708713 | Th17 Cells in Helicobacter pylori Infection: a Dichotomy of Help and Harm |
Q38708449 | The CD4+ T cell regulatory network mediates inflammatory responses during acute hyperinsulinemia: a simulation study |
Q35205390 | The NLRP1 inflammasome attenuates colitis and colitis-associated tumorigenesis |
Q34394285 | The Proteome of a Healthy Human during Physical Activity under Extreme Conditions |
Q38177338 | Translational research and efficacy of biologics in Crohn's disease: a cautionary tale |
Search more.